CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Alteplase in a Non-Stroke Centre: Clinical Benefit and Harm

Last updated: June 3, 2008
Product Line: Rapid Response
Research Type: Drug
Result type: Report


  1. What is the evidence for the clinical benefit and harm associated with alteplase treatment for stroke patients in a non-stroke centre or community hospital?
  2. Should stroke patients be transferred to a regional stroke facility for alteplase treatment?